Genomic epidemiology and antimicrobial resistance of <i>Corynebacterium macclintockiae</i> , the predominant species of human pathogens within the <i>Corynebacterium jeikeium</i> complex
Sohei Harada(University of Tokyo Hospital), Kazuhiro Tateda(Toho University), Jun Suzuki(Gifu Prefectural General Medical Center), Asako Doi(Kobe City Medical Center General Hospital), Kageto Yamada(Toho University), Tomoo Saga(Akita University Hospital), Kazumi Takehana(Japanese Foundation For Cancer Research), Masahiro Suzuki(Fujita Health University), Kohji Komori(Toho University), Koki Kikuchi(Teine Keijinkai Hospital), Kyoko Yokota(Kagawa University Hospital), Yoshiro Hadano(Shimane University Hospital), Masakazu Sasaki(Toho University), Brian Hayama(Japanese Foundation For Cancer Research), Kenya Yukawa(Toho University), Yohei Doi(Fujita Health University)
Cited by 2
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
|Journal of Antimicrobial Chemotherapy|2015|86
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
|Clinical Microbiology and Infection|2016|83